Syensqo (SYENS) Q2 2024 earnings summary

Executive summary

• Q2 2024 results were in line with expectations, with sequential improvements in sales and EBITDA, driven by strong performance in Composite Materials and Consumer & Resources, while Specialty Polymers lagged due to lower volumes and pricing.

• Free cash flow was €47 million excluding a €167 million NJDEP payment, with cash conversion at 88%; net debt stood at €1.9 billion, leverage ratio 1.3x.

• Investment in North American battery materials was rephased by up to two years, reducing annual CapEx and aligning with softer EV demand.

• Major capital moves included a €1.2 billion bond issuance, share buyback program, and acquisitions to strengthen the portfolio.

• Ongoing macroeconomic uncertainty, high inflation, and slow recovery in key end markets continued to impact demand and customer investment.

Financial highlights

• Q2 2024 net sales were €1.7 billion, down 5.9% year-over-year but up 5% sequentially; underlying EBITDA was €378 million, margin 22.1%.

• Gross profit margin was 34.1%, down 90 bps year-over-year; basic EPS was €1.51, down 24.5% year-over-year.

• Operating cash flow was €43 million; excluding NJDEP payment, €210 million.

• Net debt at €1.9 billion, with gearing at 21% and net debt leverage ratio of 1.3x.

• Cash conversion (LTM) was 77%, or 88% excluding the NJDEP payment.

Outlook and guidance

• Full-year 2024 underlying EBITDA expected at €1.4–1.475 billion; free cash flow (excluding NJDEP payment) forecast at €400–450 million; CapEx projected at €600–650 million.

• Management anticipates a return to year-over-year volume growth in H2 2024, especially in Novecare, but expects a slower recovery in Automotive, Agro, Industrial, and Medical markets.

• Q4 could see a 10–20% sequential EBITDA decline depending on seasonal trends and customer cash management.

• Net pricing reduction of €50–100 million and dissynergies (~€30 million) expected in 2024.